The stiff liver phenotype (NASH), showing close coupling with stiff adipose tissue, is characterized by ectopic fat storage and increased insulin-independent lipo/glucogenesis, functionally resulting in pronounced dyslipidemia and insulin-resistant hyperglycemia, which can lead to the development of T2D. The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.